{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:09:30Z","timestamp":1787501370807,"version":"build-2736575974"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.tube.2020.101934","type":"journal-article","created":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T19:38:27Z","timestamp":1585769907000},"page":"101934","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Diminished systemic levels of antimicrobial peptides in tuberculous lymphadenitis and their reversal after anti-tuberculosis treatment"],"prefix":"10.1016","volume":"122","author":[{"given":"Gokul Raj","family":"Kathamuthu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kadar","family":"Moideen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rathinam","family":"Sridhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhanaraj","family":"Baskaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Subash Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.tube.2020.101934_bib1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3855\/jidc.2090","article-title":"Nodal tuberculosis revisited: a review","volume":"6","author":"Handa","year":"2012","journal-title":"J Infect Dev Ctries"},{"issue":"4","key":"10.1016\/j.tube.2020.101934_bib3","doi-asserted-by":"crossref","first-page":"448","DOI":"10.4103\/ijmr.IJMR_1950_16","article-title":"Index-TB guidelines: guidelines on extrapulmonary tuberculosis for India","volume":"145","author":"Sharma","year":"2017","journal-title":"Indian J Med Res"},{"issue":"6","key":"10.1016\/j.tube.2020.101934_bib4","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.smim.2014.09.011","article-title":"Pro-and anti-inflammatory cytokines in tuberculosis: a two-edged sword in TB pathogenesis","volume":"26","author":"Etna","year":"2016","journal-title":"Semin Immunol"},{"issue":"5","key":"10.1016\/j.tube.2020.101934_bib5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nri.2016.29","article-title":"The immunology of host defence peptides: beyond antimicrobial activity","volume":"16","author":"Hancock","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"6870","key":"10.1016\/j.tube.2020.101934_bib6","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/415389a","article-title":"Antimicrobial peptides of multicellular organisms","volume":"415","author":"Zasloff","year":"2002","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.tube.2020.101934_bib7","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1586\/14787210.5.6.951","article-title":"Alternative mechanisms of action of cationic antimicrobial peptides on bacteria","volume":"5","author":"Hale","year":"2007","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"2","key":"10.1016\/j.tube.2020.101934_bib8","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0167-7799(97)01156-6","article-title":"Cationic peptides: a new source of antibiotics","volume":"16","author":"Hancock","year":"1998","journal-title":"Trends Biotechnol"},{"issue":"12","key":"10.1016\/j.tube.2020.101934_bib9","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/nbt1267","article-title":"Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies","volume":"24","author":"Hancock","year":"2006","journal-title":"Nat Biotechnol"},{"issue":"5","key":"10.1016\/j.tube.2020.101934_bib10","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.biotechadv.2016.05.007","article-title":"Antimicrobial peptides as novel anti-tuberculosis therapeutics","volume":"34","author":"Silva","year":"2016","journal-title":"Biotechnol Adv"},{"issue":"9","key":"10.1016\/j.tube.2020.101934_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184753","article-title":"Heightened circulating levels of antimicrobial peptides in tuberculosis-Diabetes co-morbidity and reversal upon treatment","volume":"12","author":"Kumar","year":"2017","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.tube.2020.101934_bib12","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.bbamem.2008.09.013","article-title":"Control of cell selectivity of antimicrobial peptides","volume":"1788","author":"Matsuzaki","year":"2009","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"10.1016\/j.tube.2020.101934_bib13","doi-asserted-by":"crossref","first-page":"128","DOI":"10.4172\/1747-0862.1000128","article-title":"Prospective tuberculosis treatment: peptides, immunity and autophagy","volume":"8","author":"Rodriguez Plaza","year":"2014","journal-title":"J Mol Genet Med"},{"issue":"4","key":"10.1016\/j.tube.2020.101934_bib14","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.coi.2008.05.014","article-title":"Human macrophage host defense against Mycobacterium tuberculosis","volume":"20","author":"Liu","year":"2008","journal-title":"Curr Opin Immunol"},{"issue":"5","key":"10.1016\/j.tube.2020.101934_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00175-13","article-title":"Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides","volume":"57","author":"Ramon-Garcia","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2020.101934_bib16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1146\/annurev.iy.11.040193.000541","article-title":"Defensins: antimicrobial and cytotoxic peptides of mammalian cells","volume":"11","author":"Lehrer","year":"1993","journal-title":"Annu Rev Immunol"},{"issue":"9","key":"10.1016\/j.tube.2020.101934_bib17","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1073\/pnas.88.9.3952","article-title":"Tracheal antimicrobial peptide, a cysteine-rich peptide from mammalian tracheal mucosa: peptide isolation and cloning of a cDNA","volume":"88","author":"Diamond","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.tube.2020.101934_bib18","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1189\/jlb.68.6.779","article-title":"Expression of mammalian defensin genes","volume":"68","author":"Kaiser","year":"2000","journal-title":"J Leukoc Biol"},{"issue":"6","key":"10.1016\/j.tube.2020.101934_bib19","doi-asserted-by":"crossref","first-page":"8686","DOI":"10.1073\/pnas.94.16.8686","article-title":"Epithelial antibiotic induced in states of disease","volume":"94","author":"Stolzenberg","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"10.1016\/j.tube.2020.101934_bib20","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1086\/424463","article-title":"Role of human neutrophil peptide-1 as a possible adjunct to antituberculosis chemotherapy","volume":"190","author":"Kalita","year":"2004","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.tube.2020.101934_bib21","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00441-010-1022-4","article-title":"Defensins in innate immunity","volume":"343","author":"Hazlett","year":"2011","journal-title":"Cell Tissue Res"},{"issue":"4","key":"10.1016\/j.tube.2020.101934_bib22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1159\/000336619","article-title":"Beta-Defensins: multifunctional modulators of infection, inflammation and more?","volume":"4","author":"Semple","year":"2012","journal-title":"J Innate Immun"},{"issue":"47","key":"10.1016\/j.tube.2020.101934_bib23","doi-asserted-by":"crossref","first-page":"18631","DOI":"10.1073\/pnas.0702130104","article-title":"Human -defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2","volume":"104","author":"Funderburg","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.tube.2020.101934_bib24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/pathogens2010013","article-title":"Defensin production by human limbo-corneal fibroblasts infected with mycobacteria","volume":"2","author":"Castaneda-Sanchez","year":"2013","journal-title":"Pathogens"},{"issue":"7\u20138","key":"10.1016\/j.tube.2020.101934_bib25","first-page":"1001","article-title":"Comparative modeling of amoebapores and granulysin based on the NK- lysin structure-structural and functional implications","volume":"380","author":"Bruhn","year":"1999","journal-title":"Biol Chem"},{"issue":"20","key":"10.1016\/j.tube.2020.101934_bib26","doi-asserted-by":"crossref","first-page":"14719","DOI":"10.1074\/jbc.M608920200","article-title":"Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against gram-negative pathogens","volume":"282","author":"Andr\u00e4","year":"2007","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.tube.2020.101934_bib27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0092-8674(95)90229-5","article-title":"Ancient weapons: NK-lysin is a mammalian homolog to pore-forming peptides of a protozoan parasite","volume":"83","author":"Leippe","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.tube.2020.101934_bib28","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.4049\/jimmunol.165.3.1486","article-title":"Bactericidal and tumoricidal activities of synthetic peptides derived from granulysin","volume":"165","author":"Wang","year":"2000","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.tube.2020.101934_bib29","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1399-0039.2008.01218.x","article-title":"Biology and clinical relevance of granulysin","volume":"73","author":"Krensky","year":"2009","journal-title":"Tissue Antigens"},{"issue":"7","key":"10.1016\/j.tube.2020.101934_bib30","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0161-5890(99)00063-2","article-title":"Biosynthesis of granulysin, a novel cytolytic molecule","volume":"36","author":"Hanson","year":"1999","journal-title":"Mol Immunol"},{"issue":"5386","key":"10.1016\/j.tube.2020.101934_bib31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1126\/science.282.5386.121","article-title":"An antimicrobial activity of cytolytic T cells mediated by granulysin","volume":"282","author":"Stenger","year":"1998","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.tube.2020.101934_bib32","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1128\/IAI.00624-07","article-title":"Impaired expression of perforin and granulysin in CD8+T cells at the site of infection in human chronic pulmonary tuberculosis","volume":"75","author":"Andersson","year":"2007","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.tube.2020.101934_bib33","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.tube.2007.01.003","article-title":"Decreased serum granulysin levels in childhood tuberculosis which reverse after therapy","volume":"87","author":"Di Liberto","year":"2007","journal-title":"Tuberculosis"},{"issue":"16","key":"10.1016\/j.tube.2020.101934_bib34","doi-asserted-by":"crossref","first-page":"9541","DOI":"10.1073\/pnas.95.16.9541","article-title":"The peptide antibiotic LL-37\/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface","volume":"95","author":"Bals","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.tube.2020.101934_bib35","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.4049\/jimmunol.177.3.1864","article-title":"Macrophages acquire neutrophil granules for antimicrobial activity against intracellular pathogens","volume":"177","author":"Tan","year":"2006","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.tube.2020.101934_bib36","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s002030050719","article-title":"Biochemical interaction of human neutrophil peptide-1 with Mycobacterium tuberculosis H37Ra","volume":"171","author":"Sharma","year":"1999","journal-title":"Arch Microbiol"},{"issue":"1","key":"10.1016\/j.tube.2020.101934_bib37","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1034\/j.1399-3003.2000.16a20.x","article-title":"Antibacterial activity of human neutrophil peptide-1 against Mycobacterium tuberculosis H37Rv: in vitro and ex vivo study","volume":"16","author":"Sharma","year":"2000","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.tube.2020.101934_bib38","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1128\/AAC.45.2.639-640.2001","article-title":"Therapeutic potential of human neutrophil peptide 1 against experimental tuberculosis","volume":"45","author":"Sharma","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.tube.2020.101934_bib39","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1378\/chest.121.2.519","article-title":"Elevated levels of alpha-defensins in plasma and BAL fluid of patients with active pulmonary tuberculosis","volume":"121","author":"Ashitani","year":"2002","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.tube.2020.101934_bib40","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1615\/CritRevImmunol.v20.i5.40","article-title":"Cationic antimicrobial peptides and their multifunctional role in the immune system","volume":"20","author":"Scott","year":"2000","journal-title":"Crit Rev Immunol"},{"issue":"5768","key":"10.1016\/j.tube.2020.101934_bib41","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1126\/science.1123933","article-title":"Toll-like receptor triggering of a vitamin D mediated human antimicrobial response","volume":"311","author":"Liu","year":"2006","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.tube.2020.101934_bib42","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V90.7.2796","article-title":"The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils","volume":"90","author":"Sorensen","year":"1997","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.tube.2020.101934_bib43","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1182\/blood.V97.12.3951","article-title":"Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3","volume":"97","author":"Sorensen","year":"2001","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.tube.2020.101934_bib44","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1128\/IAI.02016-05","article-title":"Role of polymorphonuclear leukocyte-derived serine proteinases in defense against actinobacillus actino-mycetemcomitans","volume":"74","author":"de Haar","year":"2006","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.tube.2020.101934_bib45","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.4049\/jimmunol.179.4.2060","article-title":"Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin","volume":"179","author":"Liu","year":"2007","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.tube.2020.101934_bib46","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.chom.2009.08.004","article-title":"Vitamin D3 induces autophagy in human monocytes\/macrophages via cathelicidin","volume":"6","author":"Yuk","year":"2009","journal-title":"Cell Host Microbe"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979220301013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979220301013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:43:41Z","timestamp":1761468221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979220301013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":45,"alternative-id":["S1472979220301013"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2020.101934","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diminished systemic levels of antimicrobial peptides in tuberculous lymphadenitis and their reversal after anti-tuberculosis treatment","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2020.101934","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101934"}}